Operating Company Healthcare

Fingerpaint Group

Cedar Knolls, New Jersey, United States

End-to-end life science commercialization solutions spanning the full spectrum of life sciences needs, including medical communications, branding/creative, and market access capabilities.

Focus Areas
Medical communications, Healthcare marketing, Market access
Website
fingerpaint.com

Tracked deals

7

7 tracked deals across 2021-2025.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Addon

5 addon · 2 buyout

Fingerpaint Group Acquisition Volume by Year

Last 4 years

Acquisition volume by year Annual acquisition counts for the last 4 years for Fingerpaint Group. 1 2021 2 2022 2 2023 2 2025

Supporting Data

Recent Transactions

  • Buyer
    Fingerpaint Group
    Target
    L&M Healthcare Communications
    Type
    Buyout

    Fingerpaint Group has acquired L&M Healthcare Communications, a New Jersey–based medical communications agency that serves biotech and pharmaceutical clients. The acquisition expands Fingerpaint Medical's medical communications and medical affairs capabilities; financial terms were not disclosed.

  • Buyer
    Fingerpaint Group
    Target
    BlackPoint Consulting Group
    Location
    United States
    Type
    Addon

    Fingerpaint Group announced its acquisition of BlackPoint Consulting Group, a specialized advisory firm based in New York City serving healthcare and life sciences companies. The deal strengthens Fingerpaint’s Market Access Center of Excellence by expanding its capabilities across market access and patient support for pharma clients. Financial terms were not disclosed.

  • Buyer
    Fingerpaint Group
    Target
    The MYND Group
    Type
    Addon

    Fingerpaint Group has acquired The MYND Group, a strategic market access marketing firm serving pharmaceuticals and biologics; financial terms were not disclosed. The acquisition expands Fingerpaint's market access and managed markets capabilities and is the company's second market access buy in three years as it continues to scale under PE partnership with Knox Lane.

  • Buyer
    Fingerpaint Group
    Target
    PharmaHEALTHLabs
    Type
    Addon

    Fingerpaint Group has acquired PharmaHEALTHLabs, a specialized healthcare communications agency focused on oncology and biologics, and will rebrand it as Fingerpaint Medical Communications. The acquisition deepens Fingerpaint's medical and scientific communications capabilities as part of its Specialty Services offering; financial terms were not disclosed.

  • Buyer
    Fingerpaint Group, Knox Lane
    Target
    Parsons Medical Communications
    Type
    Addon

    Fingerpaint Group, a Knox Lane–backed healthcare marketing and specialty services platform, has acquired Parsons Medical Communications (PMC), a boutique scientific communications firm focused on the eyecare segment. The acquisition expands Fingerpaint's medical communications and eyecare capabilities; financial terms and seller details were not disclosed.

  • Buyer
    Fingerpaint Marketing, Inc., Knox Lane
    Target
    Emcay, LLC
    Type
    Addon

    Fingerpaint Marketing, a Knox Lane–backed healthcare marketing agency, has acquired Emcay, a multicultural pharmaceutical marketing agency, and created Fingerpaint Multicultural to centralize Pharmacultural capabilities. Steve Millerman, former president of Emcay, will lead the new specialty offering reporting to Fingerpaint's head of marketing.

  • Buyer
    Fingerpaint
    Target
    MedThink
    Type
    Buyout

    Fingerpaint, a biopharma commercialization partner, has acquired MedThink, a North Carolina–based medical communications firm, adding medical education, medical affairs communications, and publication services to its suite of capabilities. Financial terms were not disclosed; MedThink's president Scott Goudy will continue to lead day-to-day operations, and Knox Lane (a strategic investor in Fingerpaint) supported the transaction.

Related Acquisition Pages

Selling a company? Get in front of buyers like Fingerpaint Group

Turn tracked acquisition activity into an outreach-ready buyer list.